Fig. 2.
Effect of duration of time from definitive therapy to initiation of ADT (<5 years vs. ≥5 years) on time to mCRPC. ADT = androgen deprivation therapy; mCRPC = metastatic castration-resistant prostate cancer
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.